July 15th 2025, 1:50pm
Panelists discuss the multifaceted diagnostic process for multiple myeloma, emphasizing the integration of blood tests, genetic and imaging assessments, and patient education to guide personalized treatment planning and enhance patient engagement in care.
July 15th 2025, 1:43pm
The program emphasized the importance of incorporating patient and caregiver perspectives alongside clinical expertise to support personalized, empathetic care and shared decision-making in managing the diverse and complex challenges of multiple myeloma.
July 15th 2025, 1:00pm
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
July 14th 2025, 8:00pm
Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.
July 14th 2025, 1:00pm
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
July 12th 2025, 6:00pm
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
July 11th 2025, 8:00pm
A patient on the Monjuvi trial saw lymph nodes shrink 85%, with stable results a year later, supporting the FDA’s recent approval for follicular lymphoma.
July 11th 2025, 1:00pm
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
July 10th 2025, 8:00pm
Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone living with metastatic disease.
July 10th 2025, 1:00pm
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia.
Coping With a Rare Cancer Diagnosis, Like GIST
Refining Treatment Approaches and Advancements in High-Risk Melanoma
Celebrating My Clean Bill of Health After Cancer
Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer